Short-term effect of a smart nebulizing device on adherence to inhaled corticosteroid therapy in Asthma Predictive Index-positive wheezing children

Autor:	Yaqin Li, Haojin Zhu, Qing Yu, Yuan Zhou, Yanming Lu, Yanhan Zhang
Rok vydání:	2018
Předmět:	medicine.medical_specialty medicine.drug_class Systemic steroid Medicine (miscellaneous) inhaled corticosteroid 03 medical and health sciences 0302 clinical medicine 030225 pediatrics Internal medicine Medicine Term effect adherence Pharmacology Toxicology and Pharmaceutics (miscellaneous) Original Research wheezing business.industry Health Policy Respiratory infection smart nebulizer medicine.disease Asthma predictive index Comorbidity Nebulizer Patient Preference and Adherence 030228 respiratory system Corticosteroid therapy Corticosteroid business Social Sciences (miscellaneous)
Zdroj:	Patient preference and adherence
ISSN:	1177-889X
Popis:	Yuan Zhou,1,* Yanming Lu,1,* Haojin Zhu,2 Yanhan Zhang,1 Yaqin Li,1 Qing Yu1 1Department of Pediatrics, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 201112, People’s Republic of China; 2School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, 201112, People’s Republic of China *These authors contributed equally to this work Objective: To explore the effect of a smart nebulizing device on the rate of adherence to inhaled corticosteroid (ICS) in children with positive Asthma Predictive Index. Methods: In total, 65 children with positive Asthma Predictive Index and under the age of 5 years who visited our hospital from October 2015 through October 2016, were randomly assigned to receive conventional nebulization or smart nebulization. The smart nebulizer was connected to smart phones via an App. The following information was collected: rate of adherence to ICS, frequency of emergency visits or hospitalizations, application of antibiotics or oral steroids, and wheezing progression or improvement. Results: The rate of adherence to ICS was 86.67% (26/30), 76.67% (23/30), and 67.33% (20/30) in the smart nebulization group, and 62.86% (22/35), 51.42% (18/35), and 40.00% (14/35) in the conventional nebulization group after 4-, 8-, and 12-week therapy, respectively. There were significant differences between the 2 groups at all of the time points (P
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd9604225712a3a1a1ffcd0aeba825e https://doi.org/10.2147/ppa.s162744 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.